Key Record Dates
ClinicalTrials.gov Identifier: | NCT02340975 |
---|---|
Brief Title: | A Phase 1b/2 Study of MEDI4736 With Tremelimumab, MEDI4736 or Tremelimumab Monotherapy in Gastric or GEJ Adenocarcinoma |
First Submitted : | January 14, 2015 |
First Submitted that Met QC Criteria : | January 14, 2015 |
First Posted : | January 19, 2015 (Estimate) |
Results First Submitted : | April 27, 2020 |
Results First Submitted that Met QC Criteria : | April 27, 2020 |
Results First Posted : | May 11, 2020 |
Last Update Submitted that Met QC Criteria : | June 2, 2020 |
Last Update Posted : | June 9, 2020 |